Dr Saqib Mir

Dr. Saqib Mir is a medical professional with extensive experience in medical writing and regulatory affairs, currently serving as the Director at AIXIAL GROUP since January 2025. Prior to this role, Dr. Mir held various positions at Richmond Pharmacology from January 2022 to December 2024, including Lead Physician Scientist and Head of Medical Writing and Regulatory Affairs. Dr. Mir's experience includes work as a Medical Advisor at Be Pain Free Global and engagement in algorithmic trading with MetaTrader 4, focusing on FX stocks and cryptocurrencies. Dr. Mir has also completed foundation training at Northern Lincolnshire and Goole Hospitals NHS Foundation Trust and Hull University Teaching Hospitals NHS Trust, with rotations in various medical specialties. Dr. Mir earned a Doctor of Medicine degree from the University of York, where the medical training spanned from September 2013 to August 2018.